✦ LIBER ✦

P-148 Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects

✍ Scribed by Mast, K.; Taub, J.W.; Alonzo, T.; Mosse, C.; Gamis, A.S.; Mathew, P.; Jones, H.; Hitzler, J.; Head, D.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myelodysplastic syndromes (MDS) and acut

✍ Michèle Imbert; Doyen Nguyen; Claude Sultan 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Low-dose cytosine-arabinoside in the tre

✍ Weh, H. J. ;Zschaber, R. ;Hossfeld, D. K. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 189 KB

CD99 identifies disease stem cells in ac

✍ Chung, Stephen; Pang, Wendy; Jan, Max; Klimek, Virginia; Weissman, Irving; Majet 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

P-301 Results of 5-azacitidine therapy i

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

P-274 Rigosertib activity in patients wi

✍ Navada, S.C.; Odchimar-Reissig, R.; Reddy, E.P.; Demakos, E.P.; Holland, J.F.; W 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Pharmacokinetic (PK) Comparison Of Intra

✍ D.A. Hutcherson; M. Surati; K. Sanvidge; D. Harvey; R.N. Al-Baldawi; A. Langston 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 77 KB